Necrotizing sarcoid granulomatosis with hemoptysis: a case report and literature review
- Haidong Huang†1,
- Chen Li†2,
- Chong Bai†1,
- Qiang Li1,
- Weiqiang Zheng3,
- Zhi Zhu3,
- Paul Zarogoulidis4, 5Email author,
- Konstantinos Zarogoulidis4,
- Andreas Gschwendtner6,
- Wolfgang Hohenforst-Schmidt7 and
- Michael Simoff8
© Huang et al.; licensee BioMed Central Ltd. 2013
Received: 5 March 2013
Accepted: 9 May 2013
Published: 13 May 2013
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1955868163936338
We present a case of 39-year-old male with the symptoms of fever, cough, chest pain and bloody phlegm, whose chest CT showed multiple subpleural nodules and inflammatory infiltration. Video-Assisted Thoracic Surgery ( VATS ) for right subplural nodule was performed and confirmed the diagnosis of necrotizing sarcoid granulomatosis. Prednisolone was administered and the symptoms were under control untill the occurrence of intermittent hemoptysis after 10 months. Chest CT and bronchoscope revealed the right lower lobe nodule with intraluminal necrotic tissue in the right lower lobe posterior basal segment respectively. Fatal hemoptysis happened during endobronchial biopsy by flexible bronchoscope forcep. Based on this case, we reviewed the relevant literature and discussed the clinical features, pathological changes and prognosis of the disease.
KeywordsNecrotizing sarcoid granulomatosis Granuloma Vasculitis Necrosis Bronchoscopy Hemoptysis
Necrotizing Sarcoid Granulomatosis (NSG) was firstly proposed by American Pathologists Liebow in 1973, who defined 3 classical characteristics for NSG, firstly, NSG had a background of sarcoid-like granulomata histologically, a prominent and usually granulomatous vasculitis with varying degrees of necrosis; Secondly, Radiographic features with pulmonary nodules without enlarged hilar lymph nodes ; Thirdly, Most of NSG had a benign prognosis . Compared with other lung granulomatosis, NSG is an extremly rare diagnosis and can only be identified based on large pieces of pathological tissue with characteristic pathological changes such as non-caseating epithelioid cell granulomas, granulomatous vasculitis and necrosis. NSG is sensitive to corticosteroid treatment. Although it's previously considered as a disease with good prognosis, however; relapse is common. The reports of poor progrosis as well as severe complications, even death are not rare, especially wih NSG cases under long term corticosteroid control . Here we report a case of NSG presenting with intermittent hemoptysis when corticosteroid therapy was decreased, and fatal hemoptysis occured during the follow-up. Relevant studies of this rare entity are also presented in the discussion section.
NSG is an extremely rare granulomatosis, only about 200 cases were reported in English literature in pubmed. Its etiology and pathogenesis still remains unclear. Some scholars believed that some kind of infection, such as aspergillus, chlamydia pneumoniae and immune disorder mechanism post infection involved in the pathogenesis of the NSG [2–4]. Heinrich et al.  firstly reported that reduced peripheral blood CD4/CD8 T cell ratio and increased CD4/CD8 T cell ratio at the lesions indicating immune dysfunction is involved in the pathogenesis. The antigen-antibody complexes eventually induce immune disorders and disease. Compared to the other organs, lung is rich with blood supply and the deposit of antigen-antibody is common, which makes lung the most frequently involved organ for NSG. This could also explain the occurrence of NSG associated with various autoimmune diseases, such as biliary cirrhosis, ankylosing spondylitis and rheumatoid arthritis [6, 7].
The average age for the onset of NSG is between 40–60 years and is dominant in female. NSG's clinical manifestations are normally mild and unspecific such as chest pain (63%), cough (38%), fever (30%) and general malaise (31%). In addition to the lung, multiple reports showed NSG is accompanied with skin erythema nodosum, uveitis, and involvement of the stomach, liver and central nervous system [2, 5, 6, 8–14].
In the present case, clinical manifestations such as recurrent fever and chest pain were consistent with previous reports. The current case also showed characteristics of NSG image: solitary or multiple nodules or lumps shadow of lung associated with local pleural thickening in chest radiography; Chest CT showed visible pulmonary nodules distributed subpleurally or along the bronchi and some nodules were empty. Other reported clinical manifestations included hilar lymphadenopathy (28%), pleural effusion (11%) and nodular lesions within the vacuoles (8%) [5, 6, 8, 15, 16]. NSG also shares the similarities of the migratory and varied lesions with disease like pulmonary vasculitis . It was reported that positron emission computed tomography (F-18FDG / PET-CT) had been used to check NSG patients, which was able to show the actual NSG extent, detect the SUV value of NSG lesions and guide the surgical biopsy at the same time .
Diagnosis of NSG mainly relies on pathological findings, non-caseating epithelial cell granulomas, granulomatous vasculitis and necrosis which are the main pathological features of NSG. Chronic granulomatosis caused by tuberculosis, atypical mycobacteria, fungi and parasites should be excluded for differential diagnosis. Non-caseating epithelial cell granulomas of NSG may invade the vessel wall and lumen to form granulomatous vasculitis and lesions of coagulation necrosis; lymphocytes, multinucleated giant cells and other inflammatory cells can infiltrate pulmonary blood vessel walls and cause severe stenosis or occlusion of the vessel lumen with perivascular granuloma formation [1, 6, 11, 16, 19]. The granulomatous vasculitis can lead to the ischemic necrosis surrounding the blood vessels, a unique pathological feature of NSG. In severe cases, it can cause extensive intrapulmonary coagulation necrosis and intrapulmonary hemorrhage, alveolar bleeding and widely distributed hemosiderin cells [7, 11, 20–23].
In the present case severe granuloma and necrosis at the lung nodules was observed. In consistent with the previous reports, microscopic observation showed the severe pathological vascular inflammation and necrosis (Figures 2 and 3). It's arguably believed that NSG and sarcoidosis are the same disease since NSG has pathological features of both sarcoidosis and vasculitis , they share similar non-caseating epithelial cell granulomas [2, 20, 24]. However, NSG does has distinct clinical features from sarcoidosis such as both negative serum angiotensin converting enzyme (SACE) and Kveim test. Moreover, no lung hilar and mediastinal lymph nodes are present in NSG patients and no asteroid bodies and Schaumann bodies, which are often found in sarcoidosis patients ; Granulomatous vasculitis and coagulation necrosis of NSG are generally more severe than sarcoidosis. NSG laboratory findings are also different from the systemic vasculitis (such as: Wegener granulomatosis) where the serum C-ANCA, P-ANCA are negative in NSG patients, and the granulomatous type and prognosis of NSZZG are also different. Although there are some same identical points on clinical manifestation between NSG and limited Wegener’s disease, such as either negative serum ANCA or lacking of evidence of glomerulonephritis, but actually they are completely different diseases, especially in pathological findings. The main pathological features of limited Wegeners’ in the lung including liquefaction and coagulation necrosis lesions, as well as a large number of eosinophils, and a small amount of lymphoplasmacytic infiltration, the destructive vasculitis can be found in the small pulmonary arteries and small veins. Comparing to this case, although a large number of necrosis and vasculitis could be found in the lesion, but not like NSG, the necrosis form in this case presented more like infarction necrosis post vascular obstruction due to the granulomatosis vasculitis, there was also no significant liquefaction in necrotic lesion. The inflammation cells in this case mainly composed of lynphocyte cells, rather than eosinophils cells. In this case, although there were different degrees of vascular inflammation and thickening of the vessel wall, most of the vascular wall structure still existed, rather than the destructive vasculitis such as in limited Wegners’ disease. In general, according to the pathological features in microscope of this case, we believed that this was a classical NSG case .
NSG is sensitive to corticosteroid treatment but relapse is not rare [11, 19]. Although NSG is considered as a disease with good prognosis generally, the reported cases with poor prognosis are increasingly common with in-depth understanding of the disease as well as the extended follow-up period. In a multi-center retrospective study of 14 cases with follow-up time of 18–114 months, 50% of patients demonstrated poor prognosis: 1 patient died of central nervous system infection; two cases presented lung cancer in long-term follow-up; 4 cases has recurrence . Other reports also presented severe complications with long term maintenance therapy of corticosteroids such, such as fungal infections, lung tumor and even death [2, 6–8, 26]. Therefore, clinical management requires particular attention to the NSG cases under long term long term corticosteroid treatment. Once the symptoms get worse with recent solitary nodule or cavitary lesion, further examination including biopsy is required.
In the present case, low-dose oral corticosteroid therapy was effective but hemoptysis with fever occurred during gradual reduction of corticosteroids with the image of the lower right hilar neoplasm. We considered several possibilities such as 1) NSG relapse and lung granuloma invading the vessel wall resulting in bleeding; 2) secondary pulmonary infection, such as tuberculosis, or fungal infection; 3) secondary lung tumor. Endobronchoial biopsy by flexible bronchoscope forcep normally is considered the routine approach for differential diagnosis, however unexpectedly fatal hemoptysis happened after biopsy and led to death, a rare complication which was not present in previous NSG reports. Based on the available literature, biopsy forceps clamp caused hemoptysis after bronchoscopy is common in bronchial dieulafoy disease [27, 28]. However, the patient had no past medical history of hemoptysis before, the previous chest CT scan and flexible bronchoscopy exam also did not show the basal segment abnormalities at the right lower lobe. Given the severe epithelial cells granulomatous vasculitis and extensive necrotic lesions in the pathological findings of VATS, we speculated NSG relapsed during the reduction of corticosteroid treatment. The recurrence site located in the lower right lung nearly hilar and severe granulomatous vasculitis and necrosis invaded the bronchial lumen of the basal segment as well as adjacent artery leading to the formation of bronchovascular fistula, and endobronchial biopsy procedure with mechanical force caused further damage to the bronchus and blood vessel wall. Previously two reports also showed complications of hemoptysis in the long-term follow-up process of NSG [9, 29]. After reviewing of enhanced chest CT images, we could observe a clear contrast agent enhancement at basal segment of the right lower lobe suggesting NSG granuloma may invade the blood vessels of basal segments at the right lower lung. Necrosis-like lesions caused by infection or tumor unlikely would cause such massive and rapid bleeding during biopsy. Unfortunately, the patient’s family refused autopsy. In one case study, serum interleukin-2 receptor restored to normal level with the improved condition and imaging results suggesting the value of interleukin-2 in NSG's prognosis . There is still no clear association of the severity of granulomatous vasculitis and necrosis in correlation to NSG prognosis. However, it was observed that the cases with less severe NSG granulomatous vasculitis or necrosis had better prognosis . In the present case the patient with severe lung granulomatous vasculitis and necrosis had rapid clinical relapse and lethal hemoptysis.
We firstly reported the NSG case with the fatal complication of massive hemoptysis during the flexible bronchoscope endobronchial biopsy. In particular, special attention should be paid to the patients with necrosis-like lesions during bronchoscopic biopsy to avoid lethal hemoptysis. Based on the clinical course and pathological features of our case, we presented the clinical conjecture that NSG cases with severe granulomatous vasculitis and necrosis in pathology would have a poor prognosis. So far, it's still lack of comprehensive and in-depth studies on this disease. Further studies on the etiology and pathogenesis of NSG will pave the way to the understanding of the classification, diagnosis, treatment and prognosis of NSG.
Written informed consent was obtained from the patients next of kin for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Necrotizing sarcoid granulomatosis
Serum angiotensin converting enzyme
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies
Cytoplasmic antineutrophil cytoplasmic antibodies
Human immunodeficiency virus
Positron Emission Tomography - Computed Tomography
- Liebow AA: The J. Burns Amberson lecture–pulmonary angiitis and granulomatosis. Am Rev Respir Dis. 1973, 108 (1): 1-18.PubMedGoogle Scholar
- Koss MN, Hochholzer L, Feigin DS, Garancis JC, Ward PA: Necrotizing sarcoid-like granulomatosis: clinical, pathologic, and immunopathologic findings. Hum Pathol. 1980, 11 (5 Suppl): 510-519.PubMedGoogle Scholar
- Tauber E, Wojnarowski C, Horcher E, Dekan G, Frischer T: Necrotizing sarcoid granulomatosis in a 14-yr-old female. Eur Respir J. 1999, 13 (3): 703-705. 10.1183/09031936.99.13370399.View ArticlePubMedGoogle Scholar
- Analytical Lung Pathology. Edited by: Kayser K. 1992, Heidelberg: SpringerGoogle Scholar
- Heinrich D, Gordjani N, Trusen A, Marx A, Hebestreit H: Necrotizing sarcoid granulomatosis: a rarity in childhood. Pediatr Pulmonol. 2003, 35 (5): 407-411. 10.1002/ppul.10242.View ArticlePubMedGoogle Scholar
- Churg A: Pulmonary angiitis and granulomatosis revisited. Hum Pathol. 1983, 14 (10): 868-883. 10.1016/S0046-8177(83)80162-2.View ArticlePubMedGoogle Scholar
- Le Gall F, Loeuillet L, Delaval P, Thoreux PH, Desrues B, Ramee MP: Necrotizing sarcoid granulomatosis with and without extrapulmonary involvement. Pathol Res Pract. 1996, 192 (3): 306-313. 10.1016/S0344-0338(96)80237-8. discussion 314View ArticlePubMedGoogle Scholar
- Chittock DR, Joseph MG, Paterson NA, McFadden RG: Necrotizing sarcoid granulomatosis with pleural involvement. Clinical and radiographic features. Chest. 1994, 106 (3): 672-676. 10.1378/chest.106.3.672.View ArticlePubMedGoogle Scholar
- Quaden C, Tillie-Leblond I, Delobbe A, Delaunois L, Verstraeten A, Demedts M, Wallaert B: Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J. 2005, 26 (5): 778-785. 10.1183/09031936.05.00024205.View ArticlePubMedGoogle Scholar
- Frazier AA, Rosado-de-Christenson ML, Galvin JR, Fleming MV: Pulmonary angiitis and granulomatosis: radiologic-pathologic correlation. Radiographics. 1998, 18 (3): 687-710. quiz 727View ArticlePubMedGoogle Scholar
- Strickland-Marmol LB, Fessler RG, Rojiani AM: Necrotizing sarcoid granulomatosis mimicking an intracranial neoplasm: clinicopathologic features and review of the literature. Mod Pathol. 2000, 13 (8): 909-913. 10.1038/modpathol.3880162.View ArticlePubMedGoogle Scholar
- Ahmed HM, Liang DB, Giday SA, Montgomery EA, Farmer NM: Necrotizing sarcoid granulomatosis: a case report of gastric involvement. J Hosp Med. 2010, 5 (2): 113-114. 10.1002/jhm.499.View ArticlePubMedGoogle Scholar
- Toyohara JP, Ward KM, Rabinowitz AD, Thomashow BM, Grossman ME: Necrotizing sarcoid granulomatosis with skin and pulmonary involvement. Cutis. 2007, 80 (4): 313-316.PubMedGoogle Scholar
- Ouellet S, Albadine R, Sabbagh R: Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma. Diagn Pathol. 2012, 7: 28-10.1186/1746-1596-7-28.PubMed CentralView ArticlePubMedGoogle Scholar
- Kanzawa M, Hirai C, Morinaga Y, Kawakami F, Hara S, Matsuoka H, Itoh T: Primary submucosal nodular plasmacytoma of the stomach: a poorly recognized variant of gastric lymphoma. Diagn Pathol. 2013, 8: 30-10.1186/1746-1596-8-30.PubMed CentralView ArticlePubMedGoogle Scholar
- Hammas N, Chbani L, Rami M, Boubbou M, Benmiloud S, Bouabdellah Y, Tizniti S, Hida M, Amarti A: A rare tumor of the lung: inflammatory myofibroblastic tumor. Diagn Pathol. 2012, 7: 83-10.1186/1746-1596-7-83.PubMed CentralView ArticlePubMedGoogle Scholar
- Panigada S, Ullmann N, Sacco O, Gambini C, Bush A, Rossi GA: Necrotizing sarcoid granulomatosis of the lung in a 12-year-old boy with an atypical clinical course. Pediatr Pulmonol. 2012, 47 (8): 831-835. 10.1002/ppul.22503.View ArticlePubMedGoogle Scholar
- Arfi J, Kerrou K, Traore S, Huchet V, Bolly A, Antoine M, Delaunois L, Vander Borght T, Talbot JN: F-18 FDG PET/CT findings in pulmonary necrotizing sarcoid granulomatosis. Clin Nucl Med. 2010, 35 (9): 697-700. 10.1097/RLU.0b013e3181e9fade.View ArticlePubMedGoogle Scholar
- Rolfes DB, Weiss MA, Sanders MA: Necrotizing sarcoid granulomatosis with suppurative features. Am J Clin Pathol. 1984, 82 (5): 602-607.PubMedGoogle Scholar
- Popper HH, Klemen H, Colby TV, Churg A: Necrotizing sarcoid granulomatosis–is it different from nodular sarcoidosis?. Pneumologie. 2003, 57 (5): 268-271.View ArticlePubMedGoogle Scholar
- Lin CH, Hsu CW, Tsao TY, Chou J: Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia. Diagn Pathol. 2012, 7: 2-10.1186/1746-1596-7-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Al-Jabri T, Sanjay P, Shaikh I, Woodward A: Inflammatory myofibroblastic pseudotumour of the liver in association with gall stones - a rare case report and brief review. Diagn Pathol. 2010, 5: 53-10.1186/1746-1596-5-53.PubMed CentralView ArticlePubMedGoogle Scholar
- Bergler-Czop B, Brzezinska-Wcislo L, Rogala-Poborska I: Miescher's granulomatosis (granulomatosis disciformis chronica et progressiva) in a non-diabetic patient–case report. Diagn Pathol. 2009, 4: 28-10.1186/1746-1596-4-28.PubMed CentralView ArticlePubMedGoogle Scholar
- Kitajima S, Sakai N, Furuichi K, Tomokage M, Hara A, Kitagawa K, Sawada Kitamura S, Zen Y, Nakada M, Kaneko S: A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme. Modern Rheumat. 2010, 20 (5): 506-510. 10.1007/s10165-010-0301-y.View ArticleGoogle Scholar
- Ma Y, Gal A, Koss MN: The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol. 2007, 24 (3): 150-161. 10.1053/j.semdp.2007.06.002.View ArticlePubMedGoogle Scholar
- Dykhuizen RS, Smith CC, Kennedy MM, McLay KA, Cockburn JS, Kerr KM: Necrotizing sarcoid granulomatosis with extrapulmonary involvement. Eur Respir J. 1997, 10 (1): 245-247. 10.1183/09031936.97.10010245.View ArticlePubMedGoogle Scholar
- Maxeiner H: Lethal hemoptysis caused by biopsy injury of an abnormal bronchial artery. Chest. 2001, 119 (5): 1612-1615. 10.1378/chest.119.5.1612.View ArticlePubMedGoogle Scholar
- Kuzucu A, Gurses I, Soysal O, Kutlu R, Ozgel M: Dieulafoy's disease: a cause of massive hemoptysis that is probably underdiagnosed. Ann Thorac Surg. 2005, 80 (3): 1126-1128. 10.1016/j.athoracsur.2004.02.118.View ArticlePubMedGoogle Scholar
- Palem A, Leroy S, Just N, Zanetti C, Tisseau L, Steenhouwer F, Wallaert B: [Intra-cavity aspergilloma complicating necrotising sarcoid granulomatosis]. Rev Mal Respir. 2003, 20 (4): 604-608.PubMedGoogle Scholar
- Harada T, Amano T, Takahashi A, Furuya J, Yamaguchi E, Kaji M, Morikawa T, Itoh T, Shimizu M, Nishimura M: Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levels. Respiration. 2002, 69 (5): 468-470. 10.1159/000064013.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.